Department of Respiratory Sciences, Leicester NIHR Biomedical Research Centre (Respiratory Theme), University of Leicester, Leicester, LE1 7RH, United Kingdom.
Department of Chemistry, University of Leicester, Leicester, LE1 7RH, United Kingdom.
J Breath Res. 2022 Mar 3;16(2). doi: 10.1088/1752-7163/ac5526.
Clinical assessment of children with asthma is problematic, and non-invasive biomarkers are needed urgently. Monitoring exhaled volatile organic compounds (VOCs) is an attractive alternative to invasive tests (blood and sputum) and may be used as frequently as required. Standardised reproducible breath-sampling is essential for exhaled-VOC analysis, and although the ReCIVA (Owlstone Medical Limited) breath-sampler was designed to satisfy this requirement, paediatric use was not in the original design brief. The efficacy of the ReCIVA at sampling breath from children has been studied, and 90 breath-samples from 64 children (5-15 years) with, and without asthma (controls), were collected with two different ReCIVA units. Seventy samples (77.8%) contained the specified 1 l of sampled-breath. Median sampling times were longer in children with acute asthma (770.2 s, range: 532.2-900.1 s) compared to stable asthma (690.6 s, range: 477.5-900.1 s;= 0.01). The ReCIVA successfully detected operational faults, in 21 samples. A leak, caused by a poor fit of the face mask seal was the most common (15); the others were USB communication-faults (5); and, a single instance of a file-creation error. Paediatric breath-profiles were reliably monitored, however synchronisation of sampling to breathing-phases was sometimes lost, causing some breaths not to be sampled, and some to be sampled continuously. This occurred in 60 (66.7%) of the samples and was a source of variability. Importantly, multi-variate modelling of untargeted VOC analysis indicated the absence of significant batch effects for eight operational variables. The ReCIVA appears suitable for paediatric breath-sampling. Post-processing of breath-sample meta-data is recommended to assess the quality of sample-acquisition. Further, future studies should explore the effect of pump-synchronisation faults on recovered VOC profiles, and mask sizes to fit all ages will reduce the potential for leaks and importantly, provide higher levels of comfort to children with asthma.
儿童哮喘的临床评估存在问题,迫切需要非侵入性生物标志物。监测呼出的挥发性有机化合物 (VOC) 是一种有吸引力的替代侵入性测试(血液和痰液)的方法,并且可以根据需要频繁使用。标准化可重复的呼吸采样对于呼气 VOC 分析至关重要,尽管 ReCIVA(Owlstone Medical Limited)呼吸采样器旨在满足这一要求,但最初的设计并未考虑儿科用途。已经研究了 ReCIVA 从儿童中采样呼吸的效果,使用两个不同的 ReCIVA 单元从 64 名患有和不患有哮喘(对照)的儿童中收集了 90 个呼吸样本。70 个样本(77.8%)包含指定的 1 升采样呼吸。与稳定哮喘相比,急性哮喘儿童的中位采样时间更长(770.2 秒,范围:532.2-900.1 秒;= 0.01)。ReCIVA 成功检测到 21 个样本中的操作故障。最常见的故障是面罩密封不良导致的泄漏(15 个);其他是 USB 通信故障(5 个);以及单个文件创建错误。可靠地监测了儿科呼吸谱,但是有时会失去采样与呼吸阶段的同步,导致有些呼吸未被采样,有些则连续采样。这种情况发生在 60 个(66.7%)样本中,是造成变异的一个来源。重要的是,对非靶向 VOC 分析的多变量建模表明,对于八个操作变量,不存在显著的批次效应。ReCIVA 似乎适合儿科呼吸采样。建议对呼吸样本元数据进行后处理,以评估样本采集的质量。此外,未来的研究应探索泵同步故障对恢复的 VOC 谱的影响,并应探索适合所有年龄段的面罩尺寸,以减少泄漏的可能性,重要的是,为哮喘儿童提供更高水平的舒适度。